Mark W. Schwartz Becomes The New CEO and President of Galena Biopharma Inc (NASDAQ:GALE)

Boston, MA 08/21/2114 (wallstreetpr) – According to report, the well-known biopharmaceutical company Galena Biopharma Inc (NASDAQ:GALE) has decided to appoint Mark W. Schwartz, Ph.D. as its new Chief Executive Officer and President. Previously he worked as the Executive VP and Chief Operating Officer of GALE. Schwartz will replace Mark J. Ahn, Ph.D., who has decided […]

Galena Biopharma Inc (NASDAQ:GALE) Announces Important Milestone In Drug Development

Boston, MA 06/17/2014 (wallstreetpr) – Galena Biopharma Inc (NASDAQ:GALE) has today issued an important update about its experimental ovarian and endometrial cancer treatment. In a press release, the company announced the completion of enrollment for the Phase 2a clinical trial of the drug, which is currently known as GALE-301. It said the Phase 2a trial will […]

Galena Biopharma Inc (NASDAQ:GALE): Results Update For Q1

Boston, MA 05/05/2014 (wallstreetpr) – Recently, Galena Biopharma Inc (NASDAQ:GALE) has reported that it would be releasing the results of the first quarter of 2014 soon. The company would also host a conference call in order to discuss these results, Galena Biopharma reported. The CEO if Galena Biopharma would be giving a presentation at a health […]

Galena Biopharma Inc (NASDAQ:GALE) Facing Trials For Cheating Investors

Boston, MA 04/21/2014 (wallstreetpr) – Galena Biopharma Inc (NASDAQ:GALE) is a publicly operated pharmaceutical company in the U.S. with its primary focus on cancer therapy. The company is currently facing an investigation from the US Securities and Exchange Commission. It has been charged with the allegations of using false and unlawful methods for creating hype and […]

Galena Biopharma Inc (NASDAQ:GALE) Tumbling, The Problem Of Management Oversight?

Boston, MA 04/16/2014 (wallstreetpr) – Galena Biopharma Inc (NASDAQ:GALE) is subject of the U.S. Securities Exchange Commission investigations. The biotech is facing claims of authorizing unlawful marketing campaigns that created a buzz in the stock and inflated shares, allowing insiders to make millions of dollars through the sale of thousands of shares. However, it is easy […]

Stock Highlights: Heat Biologics Inc (NASDAQ:HTBX); Growlife Inc (OTCBB:PHOT) And, Galena Biopharma Inc (NASDAQ:GALE)

Boston, MA 03/20/2014 (wallstreetpr) – Heat Biologics Inc (NASDAQ:HTBX) soared by more than 9% on Wednesday after it reported to have submitted a revised protocol to the FDA in relation to its Phase II trial of HS-110 drug. The company’s HS-110 drug is aimed at treating non-small cell cancer. The drug useslung-cancer cells that are […]

Galena Biopharma Inc (NASDAQ:GALE): When Two Is Just Too Much

Boston, MA 03/07/2014 (wallstreetpr) – Galena Biopharma Inc (NASDAQ:GALE) in a normal day should be concerned about its various drug studies in order to bring new products to the market and boost its revenue and bottom line. In other words, the company has the responsibility of maximizing value for shareholders. Yet, while the company is […]

Keep your eyes Here: General Motors Company (NYSE:GM), MGM Resorts International (NYSE:MGM), Galena Biopharma Inc (NASDAQ:GALE)

Boston, MA 02/21/2014 (wallstreetpr) – General Motors Company (NYSE:GM) recently issued recall note for more almost 800,000 cars of Pontiac and G5 and Chevrolet Cobalt models. The company cited problem with the ignition of the cars, a problem that could lead to fatal accidents in that cars are at risk of shutting off thus locking power […]

Stocks On The Move: Newcastle Investment Corp. (NYSE:NCT), GNC Holdings Inc (NYSE:GNC), Galena Biopharma Inc (NASDAQ:GALE)

Boston, MA 02/18/2014 (wallstreetpr) – Newcastle Investment Corp. (NYSE:NCT) has completed the process of spinning off its New Media division as a separate publicly traded company. It will debut on NYSE. Newcastle had earlier successfully spun off New Residential in May 2013 as a strategic move to capture the upside in the residential housing market. […]

Galena Biopharma Inc (NASDAQ:GALE) Hit By Stock Promotion, SunEdison Inc (NYSE:SUNE) and Barrick Gold Corporation (USA)(NYSE:ABX) Disappoint

Boston, MA 02/13/2014 (wallstreetpr) – Galena Biopharma Inc (NASDAQ:GALE)’s stock continued its downward spiral after it was disclosed that a leading financial website removed two articles promoting the company’s shares. It appears that both the articles were written by the same person using different aliases. The same website had earlier removed articles of the company […]

Hot Stocks Update: American Airlines Group Inc (NASDAQ:AAL), Newmont Mining Corp (NYSE:NEM), Galena Biopharma Inc (NASDAQ:GALE)

Boston, MA 02/11/2014 (wallstreetpr) – American Airlines Group Inc (NASDAQ:AAL): The benefit of combining American Airlines and US Airways to get AAL has started showing. January data show that the combined entities carried more passengers on longer distance that the same duration a year ago when you add the data from each of the companies […]

Stocks in the Spotlight: Galena Biopharma Inc (NASDAQ:GALE), Xerox Corporation (NYSE:XRX), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR)

Boston, MA 02/10/2014 (wallstreetpr) – Galena Biopharma Inc (NASDAQ:GALE): Investor confidence returned in GALE, enabling the company to close Friday’s session 15.46 percent above the previous closing. The stock had tumbled nearly 5 percent when it missed to issue yearly guidance Sovaldi, its new hepatitis C drug. Analysts and investors had hoped the company would […]

Galena Biopharma Inc. (NASDAQ:GALE) Just Another Biopharma Stock?

Boston, MA 02/04/2014 (wallstreetpr) – Does  Galena Biopharma Inc. (NASDAQ:GALE) represent just another drop in the ocean trying to become the next big thing in the biopharmaceutical field? Or, there is something more in the company that meets the eye? The stock market history contains innumerable names of companies who showed great potential but then […]

Abstral Launch By Galena Biopharma Inc (NASDAQ:GALE) In The US

Boston, MA 10/01/2013 (wallstreetpr) – After the successful launch of NeuVax drug, Galena Biopahrma Inc (NASDAQ:GALE) is all set to launch Abstral in the US drug market.  For the US launch of Abstral, Galena has collected a total amount of $37 million from a share offering. Abstral is a sublingual drug for reducing cancer pain. […]